# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA508044 | 3a | Emax | < | 80 | % | ALA2433844 | % | Homo sapiens | |||
2. | ALA508044 | 3a | EC50 | < | 156 | uM | ALA2433837 | nM | Homo sapiens | |||
3. | ALA508044 | 3a | EC50 | > | 33 | uM | ALA2433839 | nM | Homo sapiens | |||
4. | ALA508044 | 3a | EC50 | = | 0.75 | uM | ALA2433845 | 6.12 | nM | Homo sapiens | ||
5. | ALA508044 | 3a | Emax | = | 63 | % | ALA2433836 | % | Homo sapiens | |||
6. | ALA508044 | 3a | inhibition | = | 0.56 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
7. | ALA508044 | 3a | Inhibition | = | 15.436 | % | ALA4495582 | % | Severe acute respiratory syndrome coronavirus 2 | |||
8. | ALA508044 | 3a | inhibition | = | 0.56 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
9. | ALA508044 | 3a | inhibition | = | -3.31 | % | ALA4808150 | % | Homo sapiens | |||
10. | ALA508044 | 3a | inhibition | = | 6.09 | % | ALA4808149 | % | Homo sapiens | |||
11. | ALA508044 | 3a | Inhibition | = | -9.88 | % | ALA4303805 | % | Severe acute respiratory syndrome coronavirus 2 | |||
12. | ALA508044 | 3a | EC50 | = | 0.75 | uM | ALA3101955 | 6.12 | nM | Homo sapiens | ||
13. | ALA508044 | 3a | Emax | = | 100 | % | ALA3101954 | % | Homo sapiens | |||
14. | ALA508044 | 3a | EC50 | > | 80 | uM | ALA3101953 | nM | Homo sapiens | |||
15. | ALA508044 | 3a | EC50 | > | 40 | uM | ALA3101952 | nM | Homo sapiens | |||
16. | ALA508044 | 3a | EC50 | > | 33 | uM | ALA3101951 | nM | Homo sapiens | |||
17. | ALA508044 | 3a | EC50 | < | 0.156 | uM | ALA3101949 | nM | Homo sapiens | |||
18. | ALA508044 | 3a | Emax | = | 63 | % | ALA3101948 | % | Homo sapiens | |||
19. | ALA508044 | 3a | solubility | = | 113 | uM | ALA3101947 | nM | ||||
20. | ALA508044 | 3a | solubility | > | 296 | uM | ALA3101946 | nM |